Get my own profile
Public access
View all19 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Jay ShendureProfessor of Genome Sciences, University of WashingtonVerified email at uw.edu
- Richard Baker JonesIndependent biotechnology professionalVerified email at uchicago.edu
- Douglas M FowlerUniversity of WashingtonVerified email at uw.edu
- Vanessa (Gray) HaslePrincipal Scientist at Bristol Myers SquibbVerified email at bms.com
- Mark F. CiaccioAbbVie, Microwestern Life Sciences, Northwestern University, University of ChicagoVerified email at abbvie.com
- Lea StaritaUniversity of WashingtonVerified email at uw.edu
- Timothy JohnstonePrincipal Scientist, Shape TherapeuticsVerified email at shapetx.com
- M. Eileen DolanProfessor of Medicine, University of ChicagoVerified email at medicine.bsd.uchicago.edu
- Kevin P. WhiteNational University of SingaporeVerified email at nus.edu.sg
- Kin LeungUniversity of ChicagoVerified email at uchicago.edu
- Evan August BoyleStaff Scientist, Exai BioVerified email at exai.bio
- Martin KircherBerlin Institute of Health, Charité - Universitätsmedizin BerlinVerified email at uw.edu
- Kenneth A. MatreyekCase Western Reserve UniversityVerified email at case.edu
- Mary V. RellingSt. Jude Children's Research HospitalVerified email at stjude.org
- Adrian W BriggsChief Technology Officer, Shape TherapeuticsVerified email at shapetx.com
- Jacob KitzmanAssociate ProfessorVerified email at umich.edu
- Jeffrey D. Parvin, MD, PhDProfessor of Biomedical Informatics, Ohio State UniversityVerified email at osumc.edu
- Francois VigneaultCSO founder AbVitro, VP Research Juno, research fellow harvard University George Church labVerified email at abvitro.com
- Jens LuebeckUniversity of California San DiegoVerified email at ucsd.edu
- Lida Anita ToPhD Student, University of California - DavisVerified email at ucdavis.edu
Follow
Ronald J Hause, Jr.
Senior Vice President, Analytics & Informatics, Shape Therapeutics
Verified email at shapetx.com